RT Journal Article
SR Electronic
T1 Infant- and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.06.24309988
DO 10.1101/2024.07.06.24309988
A1 ,
A1 Schwinger, Catherine
YR 2024
UL http://medrxiv.org/content/early/2024/07/07/2024.07.06.24309988.abstract
AB Background Despite impressive reductions in overall global child mortality, rates of decline have slowed during the last decade. Current guidelines for the care of at-risk children in low-resource settings mostly focus on broad clinical syndromes or undernutrition rather than children’s individual contextualized risk. We aimed to identify readily assessable child-level characteristics that can predict child mortality risk in a range of community and healthcare settings in high-burden settings.Methods We analysed pooled data from 33 cohorts including 75,287 children under five years of age living in low resource settings to estimate the absolute risks of death associated with risk exposures separately and combined with anthropometry. Children were grouped according to population types studied: general population (GP), selected on anthropometric criteria (A-S), and selected on the presence of illness (I-S).Findings During a total of 69,085 child-years of follow-up in the pooled dataset, 2,805 (3.7%) children died. Age <24 months, low anthropometry, preterm birth, low birthweight, and absence of breastfeeding were each associated with increased mortality: risks were additive and declined with increasing age. However, overall mortality and the association between child-level characteristics and mortality differed according to the type of study population and child age.Interpretation Risk assessments combining individual child-level characteristics including anthropometry can enable programmes to identify children at high and lower risk of mortality and, thereafter, differentiate care accordingly. Such a strategy may reduce mortality and optimise health system efficiency and effectiveness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWHO gratefully acknowledges funding support from USAID to establish the pooled database and conduct the main analyses.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The WHO Ethics Review Committee granted an exemption in March 2022 (ERC.0003745).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesPrinciple Investigators of the individual studies can be contacted for a request to access their data.